These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure. Torp-Pedersen C; Moller M; Kober L; Camm AJ Eur Heart J; 2000 Aug; 21(15):1204-6. PubMed ID: 10924306 [No Abstract] [Full Text] [Related]
8. Dofetilide: a new class III antiarrhythmic agent. Roukoz H; Saliba W Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453 [TBL] [Abstract][Full Text] [Related]
9. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Singh SN Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718 [TBL] [Abstract][Full Text] [Related]
10. Chemical cardioversion of atrial fibrillation with intravenous dofetilide. Sedgwick ML; Lip G; Rae AP; Cobbe SM Int J Cardiol; 1995 Apr; 49(2):159-66. PubMed ID: 7628887 [TBL] [Abstract][Full Text] [Related]
11. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale. Nagra BS; Ledley GS; Kantharia BK J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):191-5. PubMed ID: 16211208 [TBL] [Abstract][Full Text] [Related]
12. [Dofetilide in patients with chronic heart failure and left ventricular dysfunction]. Latini R Ital Heart J Suppl; 2000 Mar; 1(3):427-8. PubMed ID: 10815277 [No Abstract] [Full Text] [Related]
13. Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration. Grines CL Circulation; 2000 May; 101(21):E200-1. PubMed ID: 10831533 [No Abstract] [Full Text] [Related]
14. Dofetilide (Tikosyn). Song JC; White CM Conn Med; 2000 Oct; 64(10):601-4. PubMed ID: 11100632 [No Abstract] [Full Text] [Related]
15. Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillation. Van Noord T; Van Gelder IC; Crijns HJ Circulation; 2001 Sep; 104(11):E57. PubMed ID: 11551891 [No Abstract] [Full Text] [Related]
16. Dofetilide-induced long QT and torsades de pointes. Aktas MK; Shah AH; Akiyama T Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter]. Vergara G Ital Heart J Suppl; 2001 Mar; 2(3):322-3. PubMed ID: 11307794 [No Abstract] [Full Text] [Related]
18. Dofetilide and atrial fibrillation. Benson LM; Powless D Am J Nurs; 2003 Feb; 103(2):64AA-64CC, 64EE-64GG. PubMed ID: 12582342 [No Abstract] [Full Text] [Related]
19. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide. Pedersen HS; Elming H; Seibaek M; Burchardt H; Brendorp B; Torp-Pedersen C; Køber L; Am J Cardiol; 2007 Sep; 100(5):876-80. PubMed ID: 17719337 [TBL] [Abstract][Full Text] [Related]
20. Considerations for dofetilide use in the elderly. Crist LW; Dixon DL Consult Pharm; 2014 Apr; 29(4):270-4. PubMed ID: 24704896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]